Home
Fenwick
Michael J. Shuster
Michael J. Shuster
Fenwick
JPM Conference Takeaways: Biotech And Biopharma Set For Growth In 2018
08 Feb 2018 | United States
Fenwick's Julia Forbess Talks Biotech Investment And Financing Trends (Video)
20 Nov 2017 | United States
Top Takeaways From Fenwick's Fifth Annual Digital Health Investor Summit
19 May 2016 | United States
Digital Health Investment Maintains Momentum In 2015
05 May 2015 | United States
Will Namenda IR Withdrawal Force A Legal Switch On Product Hopping?
06 Oct 2014 | United States
Top Ten Digital Health Investments Of 2013; Generating Momentum For The Year Ahead
26 Feb 2014 | United States
Containing Myriad
27 Aug 2013 | United States
Unanimous Supreme Court Decision In Ass’n For Mol. Pathology V. Myriad Genetics, Inc.
14 Jun 2013 | United States
Justices Consider Patent Process For Personalized Medicine Industry
27 Feb 2012 | United States
A Comparison Of US And EU Biosimilars Regimes
01 Feb 2012 | United States
"Classen v. Biogen Idec Et Al." - The Latest Installment In The Patent-Eligibility Arena
14 Oct 2011 | United States
Patenting Personalized Medicine Inventions
05 Sep 2011 | United States
First To File In The Unpredictable Arts: Change In Law Requires Balancing Of Competing Interests
11 Aug 2011 | United States
Getting The Prescription Right For Patenting Personalized Medicine Innovations
16 May 2011 | United States
Contact Details
California
California
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.